David Englert

Directeur Technique/Scientifique/R&D chez Axela, Inc.

Health Technology

Consumer Services

Postes actifs de David Englert

Sociétés	Poste	Début	Fin
Axela, Inc. Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.	Directeur Technique/Scientifique/R&D	30/08/2011	-

Sociétés	Poste	Début	Fin
Pharmacia LKB Biotechnology, Inc.	Corporate Officer/Principal	-	-

The State University of New York

Doctorate Degree

Internationale

Etats-Unis	3
Canada	2

Opérationnelle

Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1
Corporate Officer/Principal	1

Sectorielle

Health Technology	2
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Axela, Inc. Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.	Health Technology
Pharmacia LKB Biotechnology, Inc.

Entreprise privées

Health Technology

Pharmacia LKB Biotechnology, Inc.